Frank Takkinen
Stock Analyst at Lake Street
(0.70)
# 3,897
Out of 4,937 analysts
60
Total ratings
21.05%
Success rate
-19.28%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGHT Sight Sciences | Upgrades: Buy | $3 → $5 | $4.16 | +20.19% | 5 | Aug 8, 2025 | |
| INSP Inspire Medical Systems | Maintains: Buy | $270 → $150 | $79.14 | +89.54% | 2 | Aug 5, 2025 | |
| LUNG Pulmonx | Maintains: Buy | $12 → $8 | $1.55 | +416.13% | 2 | Jul 31, 2025 | |
| ANGO AngioDynamics | Initiates: Buy | $24 | $8.51 | +182.02% | 1 | Jul 16, 2025 | |
| BBNX Beta Bionics | Assumes: Buy | $30 | $14.73 | +103.67% | 1 | Jun 12, 2025 | |
| ELUT Elutia | Maintains: Buy | $10 → $8 | $2.01 | +298.01% | 3 | May 9, 2025 | |
| NOTV Inotiv | Maintains: Buy | $6 → $5 | $1.83 | +173.22% | 7 | May 8, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $19 → $14 | $7.21 | +94.31% | 7 | Apr 8, 2025 | |
| LNSR LENSAR | Downgrades: Hold | $16 → $15 | $12.84 | +16.82% | 2 | Mar 24, 2025 | |
| HYPR Hyperfine | Initiates: Buy | $1.5 | $1.16 | +29.31% | 1 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $13.90 | +115.83% | 1 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $26 | $13.57 | +91.60% | 3 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $30 | $10.82 | +177.26% | 4 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $5 | $3.96 | +26.26% | 2 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $3.63 | +450.96% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.41 | +107.47% | 1 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $1.72 | +365.12% | 2 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $30 | $40.95 | -26.74% | 2 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $6 | $1.53 | +292.16% | 2 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $2.50 | +60.00% | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $8.98 | +33.63% | 2 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $2.18 | +312.84% | 3 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $1.25 | +1,185.14% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $9.23 | $0.46 | +1,920.14% | 2 | Jan 18, 2023 |
Sight Sciences
Aug 8, 2025
Upgrades: Buy
Price Target: $3 → $5
Current: $4.16
Upside: +20.19%
Inspire Medical Systems
Aug 5, 2025
Maintains: Buy
Price Target: $270 → $150
Current: $79.14
Upside: +89.54%
Pulmonx
Jul 31, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $1.55
Upside: +416.13%
AngioDynamics
Jul 16, 2025
Initiates: Buy
Price Target: $24
Current: $8.51
Upside: +182.02%
Beta Bionics
Jun 12, 2025
Assumes: Buy
Price Target: $30
Current: $14.73
Upside: +103.67%
Elutia
May 9, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $2.01
Upside: +298.01%
Inotiv
May 8, 2025
Maintains: Buy
Price Target: $6 → $5
Current: $1.83
Upside: +173.22%
CVRx, Inc.
Apr 8, 2025
Maintains: Buy
Price Target: $19 → $14
Current: $7.21
Upside: +94.31%
LENSAR
Mar 24, 2025
Downgrades: Hold
Price Target: $16 → $15
Current: $12.84
Upside: +16.82%
Hyperfine
Mar 24, 2025
Initiates: Buy
Price Target: $1.5
Current: $1.16
Upside: +29.31%
Mar 17, 2025
Initiates: Buy
Price Target: $30
Current: $13.90
Upside: +115.83%
Feb 14, 2025
Maintains: Buy
Price Target: $17 → $26
Current: $13.57
Upside: +91.60%
Jan 21, 2025
Maintains: Buy
Price Target: $17 → $30
Current: $10.82
Upside: +177.26%
Jan 14, 2025
Maintains: Buy
Price Target: $4 → $5
Current: $3.96
Upside: +26.26%
Jan 8, 2025
Initiates: Buy
Price Target: $20
Current: $3.63
Upside: +450.96%
Dec 11, 2024
Initiates: Buy
Price Target: $5
Current: $2.41
Upside: +107.47%
Aug 13, 2024
Maintains: Buy
Price Target: $14 → $8
Current: $1.72
Upside: +365.12%
Jul 2, 2024
Maintains: Buy
Price Target: $28 → $30
Current: $40.95
Upside: -26.74%
Apr 3, 2024
Maintains: Buy
Price Target: $3 → $6
Current: $1.53
Upside: +292.16%
Mar 5, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $2.50
Upside: +60.00%
Dec 27, 2023
Reiterates: Buy
Price Target: $12
Current: $8.98
Upside: +33.63%
Jun 15, 2023
Maintains: Buy
Price Target: $6 → $9
Current: $2.18
Upside: +312.84%
May 18, 2023
Maintains: Buy
Price Target: $14 → $16
Current: $1.25
Upside: +1,185.14%
Jan 18, 2023
Maintains: Buy
Price Target: $31 → $9.23
Current: $0.46
Upside: +1,920.14%